Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-28 Purchase |
2022-03-30 4:31 pm |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
184,218 | $4.5429 | $836,883 | 5,963,565 (Indirect) |
View |
| 2022-03-07 Sale |
2022-03-09 5:34 pm |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
10,000 | $17.16 | $171,629 | 98,413 (Direct) |
View |
| 2021-08-02 Purchase |
2021-08-04 6:20 pm |
Icosavax Inc. | ICVX | NanoDimension III L.P. NanoDimension III Management Ltd NanoDimension III GP Limited Partnership Nicholson Jonathan Former 10% Owner |
133,334 | $15 | $2,000,010 | 2,883,329 (Indirect Direct) |
View |
| 2021-08-02 Purchase |
2021-08-04 4:31 pm |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2,666,666 | $15 | $39,999,990 | 638,668 (Indirect) |
View |
| 2021-08-02 Purchase |
2021-08-03 6:56 pm |
Icosavax Inc. | ICVX | Gould Terry P Director |
133,334 | $15 | $2,000,010 | 256,783 (Indirect) |
View |
| 2021-08-02 Purchase |
2021-08-03 6:24 pm |
Icosavax Inc. | ICVX | ADAMS STREET PARTNERS LLC Former 10% Owner |
133,334 | $15 | $2,000,010 | 256,783 (Indirect) |
View |
| 2021-08-02 Purchase |
2021-08-02 9:27 pm |
Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Former 10% Owner |
221,351 | $15 | $3,320,265 | 3,523,561 (Direct) |
View |
| 2021-08-02 Purchase |
2021-08-02 9:20 pm |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
6,666 | $15 | $99,990 | 168,656 (Direct) |
View |
| 2021-08-02 Purchase |
2021-08-02 8:34 pm |
Icosavax Inc. | ICVX | Sanofi 10% Owner |
66,667 | $15 | $1,000,005 | 3,155,169 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-28 Exercise |
2022-03-30 6:42 pm |
N/A 2030-05-10 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
4,789 | $0 | 1,065,203 (Direct) |
View |
| 2022-03-28 Exercise |
2022-03-30 6:42 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
4,789 | $0.84 | 1,065,203 (Direct) |
View |
| 2022-03-18 Exercise |
2022-03-22 4:36 pm |
N/A 2029-12-01 |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
35,137 | $0 | 161,163 (Direct) |
View |
| 2022-03-18 Exercise |
2022-03-22 4:36 pm |
N/A N/A |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
35,137 | $0.84 | 161,163 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-16 5:22 pm |
N/A 2029-09-12 |
Icosavax Inc. | ICVX | Richardson Charles E SVP, Technical Operations |
72,561 | $0 | 227,532 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-16 5:22 pm |
N/A N/A |
Icosavax Inc. | ICVX | Richardson Charles E SVP, Technical Operations |
6,186 | $1.04 | 227,532 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-16 5:22 pm |
N/A N/A |
Icosavax Inc. | ICVX | Richardson Charles E SVP, Technical Operations |
66,375 | $0.84 | 227,532 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:09 pm |
N/A 2032-02-09 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
393,444 | $0 | 1,398,777 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:08 pm |
N/A 2032-02-09 |
Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer |
92,214 | $0 | 126,380 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:07 pm |
N/A 2032-02-09 |
Icosavax Inc. | ICVX | Richardson Charles E SVP, Technical Operations |
82,992 | $0 | 161,875 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:06 pm |
N/A 2032-02-09 |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
101,435 | $0 | 324,509 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:04 pm |
N/A 2032-02-09 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
101,435 | $0 | 428,023 (Direct) |
View |
| 2021-12-31 Gift |
2022-02-14 7:04 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
10,000 | $0 | 428,023 (Indirect) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:03 pm |
N/A 2032-02-09 |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
110,656 | $0 | 197,813 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:02 pm |
N/A N/A |
Icosavax Inc. | ICVX | Bekiroglu Elizabeth General Counsel & Corp. Sec. |
82,992 | $0 | 110,742 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-04 6:25 pm |
N/A 2030-08-06 |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
52,752 | $0 | 354,566 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-04 6:25 pm |
N/A N/A |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
38,947 | $1.04 | 354,566 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-04 6:25 pm |
N/A N/A |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
13,805 | $0.84 | 354,566 (Direct) |
View |
| 2022-01-26 Exercise |
2022-01-28 6:04 pm |
N/A 2030-05-10 |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
90,693 | $0 | 843,200 (Direct) |
View |
| 2022-01-26 Exercise |
2022-01-28 6:04 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
73,929 | $1.04 | 843,200 (Direct) |
View |
| 2021-12-21 Gift |
2022-01-28 6:04 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
125,000 | $0 | 843,200 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 6:04 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
16,764 | $0.84 | 843,200 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:34 pm |
N/A 2032-01-02 |
Icosavax Inc. | ICVX | Shiver John W. Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 5:13 pm |
N/A 2029-12-01 |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
22,598 | $0 | 148,241 (Direct) |
View |
| 2021-11-15 Exercise |
2021-11-17 5:13 pm |
N/A N/A |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
22,598 | $0.83 | 148,241 (Direct) |
View |
Ownership |
2021-09-21 9:48 pm |
N/A N/A |
Icosavax Inc. | ICVX | Bekiroglu Elizabeth See Remarks |
0 | $0 | 250,000 (Direct) |
View |
| 2021-08-02 Conversion |
2021-08-04 6:20 pm |
N/A N/A |
Icosavax Inc. | ICVX | NanoDimension III L.P. NanoDimension III Management Ltd NanoDimension III GP Limited Partnership Nicholson Jonathan Former 10% Owner |
14,178,151 | $0 | 2,883,329 (Indirect) |
View |
| 2021-08-02 Conversion |
2021-08-04 4:31 pm |
N/A N/A |
Icosavax Inc. | ICVX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
16,048,053 | $0 | 638,668 (Indirect) |
View |
| 2021-08-02 Conversion |
2021-08-04 4:02 pm |
N/A N/A |
Icosavax Inc. | ICVX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
426,393 | $0 | 426,393 (Indirect) |
View |
| 2021-08-02 Conversion |
2021-08-03 6:56 pm |
N/A N/A |
Icosavax Inc. | ICVX | Gould Terry P Director |
16,802,737 | $0 | 256,783 (Indirect) |
View |
| 2021-08-02 Conversion |
2021-08-03 6:24 pm |
N/A N/A |
Icosavax Inc. | ICVX | ADAMS STREET PARTNERS LLC Former 10% Owner |
16,802,737 | $0 | 256,783 (Indirect) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:32 pm |
N/A N/A |
Icosavax Inc. | ICVX | Richardson Charles E See Remarks |
27,750 | $15 | 78,883 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:29 pm |
N/A N/A |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
27,750 | $15 | 62,893 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:27 pm |
N/A N/A |
Icosavax Inc. | ICVX | Veneman Ann M Director |
8,500 | $15 | 8,500 (Direct) |
View |
| 2021-08-02 Conversion |
2021-08-02 9:27 pm |
N/A N/A |
Icosavax Inc. | ICVX | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC MCDADE MARK Former 10% Owner |
17,066,543 | $0 | 3,523,561 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:26 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
41,500 | $15 | 334,922 (Direct) |
View |
| 2021-08-02 Conversion |
2021-08-02 9:26 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
270,365 | $0 | 334,922 (Indirect) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:25 pm |
N/A N/A |
Icosavax Inc. | ICVX | FIELDS HEIDI Director |
8,750 | $15 | 8,750 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:23 pm |
N/A N/A |
Icosavax Inc. | ICVX | Simpson Adam K. Chief Executive Officer |
125,000 | $15 | 914,640 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:20 pm |
N/A N/A |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
41,500 | $15 | 168,656 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:19 pm |
N/A N/A |
Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer |
32,500 | $15 | 32,500 (Direct) |
View |
| 2021-08-02 Conversion |
2021-08-02 8:34 pm |
N/A N/A |
Icosavax Inc. | ICVX | Sanofi 10% Owner |
15,923,393 | $0 | 3,155,169 (Indirect) |
View |
Ownership |
2021-07-28 9:29 pm |
N/A N/A |
Icosavax Inc. | ICVX | Gould Terry P Director 10% Owner |
0 | $0 | 3,259,055 (Indirect) |
View |
Ownership |
2021-07-28 9:26 pm |
N/A N/A |
Icosavax Inc. | ICVX | Cearley Cassia Chief Business Officer |
0 | $0 | 488,420 (Direct) |
View |
Ownership |
2021-07-28 9:24 pm |
N/A 2031-05-28 |
Icosavax Inc. | ICVX | FIELDS HEIDI Director |
0 | $0 | 25,266 (Direct) |
View |
Ownership |
2021-07-28 9:23 pm |
N/A N/A |
Icosavax Inc. | ICVX | Kanesa-thasan Niranjan Chief Medical Officer |
0 | $0 | 551,216 (Direct) |
View |
Ownership |
2021-07-28 9:23 pm |
N/A N/A |
Icosavax Inc. | ICVX | Yamada Tadataka Director |
0 | $0 | 1,298,340 (Direct) |
View |
Ownership |
2021-07-28 9:23 pm |
N/A 2031-06-06 |
Icosavax Inc. | ICVX | Russo Thomas Joseph Chief Financial Officer |
0 | $0 | 474,090 (Direct) |
View |
Ownership |
2021-07-28 9:22 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
0 | $0 | 651,785 (Direct) |
View |